Cargando…

Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-Analysis

BACKGROUND: Treatment of schizophrenia with first- and second-generation antipsychotics has been associated with elevated prolactin levels, which may increase the risk for prolactin-related adverse events. METHODS: Randomized controlled trials (RCTs) included in a recent systematic review were consi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balijepalli, Chakrapani, Druyts, Eric, Zoratti, Michael J., Wu, Ping, Kanji, Salmaan, Rabheru, Kiran, Yan, Kevin, Thorlund, Kristian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899856/ https://www.ncbi.nlm.nih.gov/pubmed/29805808 http://dx.doi.org/10.1155/2018/1543034

Ejemplares similares

Prolactin-related adverse events and change in prolactin levels in pediatric patients given antipsychotics for schizophrenia and schizophrenia spectrum disorders: A systematic review
por: Druyts, Eric, et al.
Publicado: (2016)

The risk of elevated prolactin levels in pediatric patients exposed to antipsychotics for the treatment of schizophrenia and schizophrenia spectrum disorders: protocol for a systematic review and meta-analysis
por: Druyts, Eric, et al.
Publicado: (2014)

Hypoglycemia: a review of definitions used in clinical trials evaluating antihyperglycemic drugs for diabetes
por: Balijepalli, Chakrapani, et al.
Publicado: (2017)

The Impact of Digital Therapeutics on Current Health Technology Assessment Frameworks
por: Yan, Kevin, et al.
Publicado: (2021)

On Pandemic Preparedness: How Well is the Modeling Community Prepared for COVID-19?
por: Desai, Kamal, et al.
Publicado: (2020)

Epidemiology of Atypical Hemolytic Uremic Syndrome: A Systematic Literature Review
por: Yan, Kevin, et al.
Publicado: (2020)

Antipsychotic medication for women with schizophrenia spectrum disorders
por: Brand, Bodyl A., et al.
Publicado: (2022)

Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
por: Kirino, Eiji
Publicado: (2017)

Antipsychotic medication for women with schizophrenia spectrum disorders – CORRIGENDUM
por: Brand, Bodyl A., et al.
Publicado: (2023)

Prolactin and Family Psychiatric History in Schizophrenia
por: Bouguerra, I., et al.
Publicado: (2023)

PB1935: CARDIOTOXICITY AND SAFETY OF BRUTON’S TYROSINE KINASE INHIBITORS: A REVIEW OF REAL-WORLD OBSERVATIONAL EVIDENCE
por: Balijepalli, Chakrapani, et al.
Publicado: (2023)

Quality of Life in Wilson’s Disease: A Systematic Literature Review
por: Balijepalli, Chakrapani, et al.
Publicado: (2021)

Can Standard Health Technology Assessment Approaches Help Guide the Price of Orphan Drugs in Canada? A Review of Submissions to the Canadian Agency for Drugs and Technologies in Health Common Drug Review
por: Balijepalli, Chakrapani, et al.
Publicado: (2020)

Prolactin levels and agressive behaviour in men with Schizophrenia
por: Bouguerra, I., et al.
Publicado: (2023)

T192. THE GUT MICROBIOME IN SCHIZOPHRENIA AND ANTIPSYCHOTIC INDUCED METABOLIC DYSFUNCTION
por: Kanji, Sarah, et al.
Publicado: (2018)

SERUM PROLACTIN LEVEL AND SEVERITY OF PSYCHOPATHOLOGY IN PATIENTS OF SCHIZOPHRENIA
por: Shrivastava, Amresh, et al.
Publicado: (2000)

Prolactin and Psychopathology in Schizophrenia: A Literature Review and Reappraisal
por: Rajkumar, Ravi Philip
Publicado: (2014)

Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons
por: Balijepalli, Chakrapani, et al.
Publicado: (2018)

T216. VARIATION IN SIDE EFFECTS TO ANTIPSYCHOTIC TREATMENT ACROSS SCHIZOPHRENIA SPECTRUM DISORDERS
por: Susanne Neumeier, Maria, et al.
Publicado: (2020)

Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety
por: Laszlovszky, István, et al.
Publicado: (2021)

Prolactin response to antipsychotics: An inpatient study
por: Dehelean, Liana, et al.
Publicado: (2020)

SVR12 is higher than SVR24 in treatment-naïve hepatitis C genotype 1 patients treated with peginterferon plus ribavirin
por: Thorlund, Kristian, et al.
Publicado: (2014)

Minimal Effects of Cariprazine on Prolactin Levels in Bipolar Disorder and Schizophrenia
por: Culpepper, Larry, et al.
Publicado: (2022)

Cost of antipsychotic polypharmacy in the treatment of schizophrenia
por: Zhu, Baojin, et al.
Publicado: (2008)

Comparative effectiveness of antipsychotic drugs in schizophrenia
por: Stroup, T. Scott, et al.
Publicado: (2000)

The heterogeneity of antipsychotic response in the treatment of schizophrenia
por: Case, M., et al.
Publicado: (2011)

New atypical antipsychotics for schizophrenia: iloperidone
por: Caccia, Silvio, et al.
Publicado: (2010)

Osteoporosis Associated with Antipsychotic Treatment in Schizophrenia
por: Wu, Haishan, et al.
Publicado: (2013)

Antipsychotic agents: efficacy and safety in schizophrenia
por: de Araújo, Arão Nogueira, et al.
Publicado: (2012)

Polypharmacy Management of Antipsychotics in Patients with Schizophrenia
por: Kamei, Hiroyuki
Publicado: (2022)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
por: Ren, Xinhua S, et al.
Publicado: (2009)

Predictors for Antipsychotic Dosage Change in the First Year of Treatment in Schizophrenia Spectrum and Bipolar Disorders
por: Ringen, Petter Andreas, et al.
Publicado: (2019)

Prolactin and Thyroid Stimulating Hormone (TSH) Levels and Sexual Dysfunction in Patients with Schizophrenia Treated with Conventional Antipsychotic Medication: A Cross-Sectional Study
por: Zhang, Yunqiao, et al.
Publicado: (2018)

Comparison of Plasma Neurosteroid and Prolactin Levels in Patients with Schizophrenia and Healthy Individuals
por: Riahi, Forough, et al.
Publicado: (2016)

Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia
por: Yang, Fuyin, et al.
Publicado: (2018)

Effect of Brexpiprazole on Prolactin: An Analysis of Short- and Long-Term Studies in Schizophrenia
por: Ivkovic, Jelena, et al.
Publicado: (2019)

Serum Prolactin and Bone Mineral Density in Schizophrenia: A Systematic Review
por: Lally, John, et al.
Publicado: (2019)

The Effects of Antipsychotics on Prolactin Levels and Women's Menstruation
por: Bargiota, S. I., et al.
Publicado: (2013)

Nonergot dopamine-receptor agonists for treating Parkinson’s disease – a network meta-analysis
por: Thorlund, Kristian, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_413jc85goj6b99dg5522lqhpgk